These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1978488)

  • 1. Plasma concentration of remoxipride in relation to antipsychotic effect and adverse symptoms. The Canadian Remoxipride Study Group.
    Jostell KG; Lapierre YD
    Acta Psychiatr Scand Suppl; 1990; 358():48-50. PubMed ID: 1978488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.
    Laux G; Klieser E; Schröder HG; Dittmann V; Unterweger B; Schubert H; König P; Schöny HW; Bunse J; Beckmann H
    Acta Psychiatr Scand Suppl; 1990; 358():125-9. PubMed ID: 1978471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol.
    Patris M; Agussol P; Alby JM; Brion S; Burnat G; Castelnau D; Deluermoz S; Dufour H; Ferreri M; Goudemand M
    Acta Psychiatr Scand Suppl; 1990; 358():78-82. PubMed ID: 1978497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and pharmacokinetics of remoxipride after intramuscular administration.
    Kahn JP; Yisak W; Albaret C; Nilsson L; Zaar-Hedin A; Laxenaire M
    Acta Psychiatr Scand Suppl; 1990; 358():51-3. PubMed ID: 1978489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia.
    Pflug B; Bartels M; Bauer H; Bunse J; Gallhofer B; Haas S; Kanzow WT; Klieser E; Küfferle B; Stein D
    Acta Psychiatr Scand Suppl; 1990; 358():142-6. PubMed ID: 1978475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
    Lindström LH; Wieselgren IM; Struwe G; Kristjansson E; Akselson S; Arthur H; Andersen T; Lindgren S; Norman O; Naimell L
    Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
    Ahlfors UG; Rimön R; Appelberg B; Hagert U; Harma P; Katila H; Mahlanen A; Mehtonen OP; Naukkarinen H; Outakoski J
    Acta Psychiatr Scand Suppl; 1990; 358():99-103. PubMed ID: 1978501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
    Den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG
    Psychopharmacology (Berl); 1990; 102(1):76-84. PubMed ID: 1975448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial.
    Lapierre YD; Nair NP; Chouinard G; Awad AG; Saxena B; Jones B; McClure DJ; Bakish D; Max P; Manchanda R
    Acta Psychiatr Scand Suppl; 1990; 358():72-7. PubMed ID: 1978496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences of long-term treatment with remoxipride: efficacy and tolerability.
    Wålinder J; Holm AC
    Acta Psychiatr Scand Suppl; 1990; 358():158-63. PubMed ID: 1978477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety evaluation in both short- and long-term treatment of schizophrenia with remoxipride.
    Morrison D; Englund A; Lawrie V; Lewander T; Schlachet A; Westerbergh SE
    Acta Psychiatr Scand Suppl; 1990; 358():164-9. PubMed ID: 1978478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of remoxipride controlled release and immediate release capsules in schizophrenic patients.
    Widerlöv E; Franzén G; Jansson P; Movin G
    Int Clin Psychopharmacol; 1990 Apr; 5(2):125-34. PubMed ID: 1974271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics.
    Soni SD; Tench D; Ashwood TJ; Movin G
    Acta Psychiatr Scand Suppl; 1990; 358():45-7. PubMed ID: 1978487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.
    Deo R; Soni S; Rastogi SC; Levine S; Plant I; Edwards JG; Mitchell M; Chanas A
    Acta Psychiatr Scand Suppl; 1990; 358():120-4. PubMed ID: 1978470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.
    den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG
    Acta Psychiatr Scand Suppl; 1990; 358():108-10. PubMed ID: 1978468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
    Andersen J; Kørner A; Ostergaard P; Fensbo C; Birket-Smith M; Thiesen S; Hansen NR; Fogh M; Kristensen M; Møller-Nielsen EM
    Acta Psychiatr Scand Suppl; 1990; 358():104-7. PubMed ID: 1978467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive disturbances in neuroleptic therapy.
    Strauss WH; Klieser E
    Acta Psychiatr Scand Suppl; 1990; 358():56-7. PubMed ID: 1978491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
    Hebenstreit GF; Laux G; Schubert H; Beckmann H; Amman J; Bunse J; Eikmeier G; Geretsegger C; Kanitz RD; Kanzow WT
    Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme.
    Lewander T; Westerbergh SE; Morrison D
    Acta Psychiatr Scand Suppl; 1990; 358():92-8. PubMed ID: 1978500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients.
    Lahdelma RL; Appelberg B; Kuoppasalmi K; Katila H; Rimón R
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):535-40. PubMed ID: 1688013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.